Age-dependent levels of plasma neuropeptides in normal children.
Several neuropeptides are secreted in high amounts in pediatric tumors such as neuroblastoma and have been used as markers of residual or recurrent disease. Plasma levels of neuropeptides might be expected to change during development, but have not been determined in normal children. We have obtained fresh plasma from cord blood of six full-term infants and from peripheral blood in 41 healthy children, ages 1 month to 21 years. Levels of six neuropeptides, vasoactive intestinal peptide (VIP), somatostatin, gastrin releasing peptide (GRP), substance P, pancreastatin and neuropeptide Y (NPY) were measured by radioimmunoassay along with insulin-like growth factor-1 (IGF-1) whose plasma levels are known to vary during development. A child with neuroblastoma was treated with the somatostatin analogue, octreotide, and the effect on plasma neuropeptides quantified. Octreotide doses of 2-3 microg/kg daily resulted in a 40-60% decrease in plasma levels of IGF-1, pancreastatin and GRP. These results are the first publication of plasma neuropeptide levels in normal children.
O'Dorisio
M Sue
MS
Department of Pediatrics, University of Iowa, Iowa City, IA, USA. sue-odorisio@uiowa.edu
Hauger
Marsha
M
O'Dorisio
Thomas M
TM
D000293:Adolescent; D000328:Adult; D000375:Aging / Q000097:blood*; D002648:Child; D002675:Child, Preschool; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007258:Informed Consent; D007334:Insulin-Like Growth Factor I / Q000032:analysis; D009479:Neuropeptides / Q000097:blood*; D011863:Radioimmunoassay
D009479:Neuropeptides; D007334:Insulin-Like Growth Factor I